Home » AMEXDRUG CORPORATION TO ACQUIRE DERMAGEN, INC.
AMEXDRUG CORPORATION TO ACQUIRE DERMAGEN, INC.
Amexdrug Corporation (OTC BB: AXRX) announced today that it has signed an agreement to acquire all of the business assets and shares of stock of Dermagen, Inc., a California corporation. Mr. Jack Amin, President and CEO of Amexdrug Corporation believes this acquisition is expected to increase future profit margins for Amexdrug Corporation, and will be a good acquisition for Amexdrug Corporation. He is planning to open offices in Asia, and to distribute Dermagen products in countries overseas.
Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=93686)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May